ACTITREXX GMBH

actitrexx-gmbh-logo

ActiTrexx GmbH is a biotech start-up. They offer cellular therapy to prevent inflammatory reactions in conditions like GVHD, solid organ transplantation, and autoimmune diseases. Their ATREGA is a treatment option for transplanted patients, providing a substantial survival rate.

#SimilarOrganizations #People #Financial #Website #More

ACTITREXX GMBH

Social Links:

Industry:
Biotechnology

Founded:
2019-01-01

Address:
Mainz, Rheinland-Pfalz, Germany

Country:
Germany

Website Url:
http://www.actitrexx.de

Total Employee:
1+

Status:
Active

Email Addresses:
info@actitrexx.de

Total Funding:
3.5 M EUR

Technology used in webpage:
Euro German Server Location


Similar Organizations

chimeron-bio-logo

Chimeron Bio

Chimeron Bio develops agents for personalized cancer gene therapy.

fabricnano-logo

FabricNano

FabricNano is a cell-free biomanufacturing company that develops biocatalysts to unlock the future of biochemistry.

maze-therapeutics-logo

Maze Therapeutics

Maze Therapeutics is an operator of a biotechnology firm used to focus on translating genetic insights into new medicines.

obsidian-therapeutics-logo

Obsidian Therapeutics

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

treefrog-therapeutics-logo

TreeFrog Therapeutics

TreeFrog Therapeutics is a stem cell company that will enable millions of patients to access the medical revolution of cell therapies.

trevarx-biomedical-logo

Trevarx Biomedical

Trevarx Biomedical is a biomedical startup that develops new radiopharmaceuticals.

verismo-therapeutics-logo

Verismo Therapeutics

Verismo Therapeutics develops novel chimeric antigen receptors (CARs) that enhance T-cell-based cellular immunotherapy for cancer.

Current Employees Featured

andrea-tüttenberg_image

Andrea Tüttenberg
Andrea Tüttenberg Co-Founder and CEO @ ActiTrexx GmbH
Co-Founder and CEO

Founder


andrea-tüttenberg_image

Andrea Tüttenberg

Investors List

high-tech-gründerfonds_image

HTGF | High-Tech Gruenderfonds

HTGF | High-Tech Gruenderfonds investment in Series A - ActiTrexx GmbH

mediventures_image

MediVentures

MediVentures investment in Series A - ActiTrexx GmbH

lbbw-venture-capital-gmbh_image

LBBW VC

LBBW VC investment in Series A - ActiTrexx GmbH

investitions-und-strukturbank-rheinland-pfalz_image

Investitions- und Strukturbank Rheinland-Pfalz

Investitions- und Strukturbank Rheinland-Pfalz investment in Series A - ActiTrexx GmbH

Official Site Inspections

http://www.actitrexx.de Semrush global rank: 13.05 M Semrush visits lastest month: 78

  • Host name: 217-160-0-137.elastic-ssl.ui-r.com
  • IP address: 217.160.0.137
  • Location: Germany
  • Latitude: 51.2993
  • Longitude: 9.491
  • Timezone: Europe/Berlin

Loading ...

More informations about "ActiTrexx GmbH"

Home - ActiTrexx

At ActiTrexx we are developing novel therapies based on activated regulatory T cells (Treg). We aim to bring back tolerance to patients with dysfunctional immune system. Our goal is to tackle the root cause of autoimmune and …See details»

About Us - ActiTrexx

ABOUT US We were founded to provide novel treatments to patients suffering from severe autoinflammatory and autoimmune diseases with high medical need. The need to cure drives …See details»

ActiTrexx GmbH - Crunchbase Company Profile & Funding

ActiTrexx GmbH is a biotech start-up. They offer cellular therapy to prevent inflammatory reactions in conditions like GVHD, solid organ transplantation, and autoimmune diseases. …See details»

ActiTrexx GmbH - Drug pipelines, Patents, Clinical trials - Synapse

Clinical Trials associated with ActiTrexx GmbH CTIS2024-516599-14-00 / Not yet recruiting Safety, Tolerability and Feasibility of Treatment with GP120-activated Regulatory T cells …See details»

ActiTrexx - VentureRadar

"ActiTrexx GmbH is a spin-off from the University Medical Center Mainz and was founded in 2020. The company develops ATreg, a cell therapy based on activated regulatory T cells that are …See details»

ActiTrexx GmbH - Life-Sciences-Europe.com

Oct 21, 2020 ActiTrexx GmbH is a spin-off from the University Medical Center Mainz and was founded in 2020. The company develops ATreg, a cell therapy based on activated regulatory T …See details»

Company Information - RocketReach

ActiTrexx GmbH is a new biotech start up and was founded in 2020. Our vision is to offer a curative cellular therapy to prevent inflammatory reactions in conditions like GvHD, solid organ …See details»

ActiTrexx • Life Sciences - HTGF

Actitrexx is a life science startup in Darmstadt Part of the #HTGFFamily since 2021 HTGF Manager: Dr. Natalya Baltrukovich Read more here ... info@actitrexx.de Web: …See details»

ActiTrexx GmbH - Mainz, Germany - bionity.com

Mar 4, 2021 actitrexx.de. Contact. Profile News. Contact. About ActiTrexx. Mission & Vision: ATreg – For a life without Transplant Rejection. Graft-versus-Host-Disease (GvHD) is a …See details»

ActiTrexx - LBBW Venture Capital

Actitrexx, a spin-off from the University Mainz, develops ATreg, a cellular therapy with activated regulatory T cells produced within 24hrs by a proprietary automated process. ATreg suppresses undesired immune responses and inflammatory …See details»

Actitrexx Company Profile 2024: Valuation, Funding & Investors

Www.actitrexx.de. Ownership Status. Privately Held (backing) Financing Status. Venture Capital-Backed. Corporate Office. ... LBBW Venture Capital, MediVentures, and Rheinland-Pfalz …See details»

Technology - ActiTrexx

At ActiTrexx, we have developed a novel platform approach that is different. We don‘t require high numbers of Treg that have been generated by expansion. We take well defined numbers of …See details»

ActiTrexx GmbH - Bio-Equip

Mar 20, 2024 ActiTrexx GmbH was founded in 2020 as a spin-off from the University Medical Center Mainz and is backed by LBBW Venture Capital GmbH, High-Tech Gründerfonds …See details»

ActiTrexx GmbH Overview | SignalHire Company Profile

ActiTrexx GmbH is a new biotech start up and was founded in 2020. Our vision is to offer a curative cellular therapy to prevent inflammatory reactions in conditions like GvHD, solid organ …See details»

ActiTrexx | EU-Startups

ActiTrexx GmbH is a new biotech start up and was founded in 2020. Our vision is to offer a curative cellular therapy to prevent inflammatory reactions in conditions like GvHD, solid organ …See details»

ActiTrexx News Archive - ActiTrexx

ActiTrexx treats first patient with novel regulatory T cell therapy against Graft-versus-Host Disease Conny 2024-12-16T11:02:29+00:00 Pioniergeist Preisverleihung 2022 ActiTrexx erhält den mit …See details»

ActiTrexx Company Profile - Office Locations, Competitors, …

ActiTrexx GmbH is a biotechnology company that offers therapeutic cell therapies to prevent inflammatory reactions in diseases such as GvHD, solid organ transplants, and autoimmune …See details»

Newly founded biotech company ActiTrexx receives funding of € …

As the first company, alongside the Life Science Factory team, we moved to the new Sartorius quarter on Weender Landstrasse on January 1st, 2022. We are enthusiastic about the 4 floors …See details»

ActiTrexx - Overview, News & Similar companies | ZoomInfo.com

View ActiTrexx (www.actitrexx.de) location in Rheinland-Pfalz, Germany , revenue, industry and description. Find related and similar companies as well as employees by title and much more.See details»

SAT.1 Regionalmagazin features ActiTrexx GmbH as an example …

SAT.1 Regionalmagazin features ActiTrexx GmbH as an example for a biotech start-up in Rhineland-Palatinate. Guest in the studio: The biotechnology commissioner of Rhineland …See details»

linkstock.net © 2022. All rights reserved